11,13-modified saxitoxins for the treatment of pain
US10112953B2 · kind B2 · utility
3Cited by
4References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 30, 2016 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Sep 30, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating conditions associated with voltage-gated sodium channel function where the compounds are 11,13-modified saxitoxins according to Formula (I): where R1, X1 and X3 are as described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.